Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Accolade Inc (NQ: ACCD )

8.250 -0.940 (-10.23%)
Streaming Delayed Price Updated: 11:11 AM EDT, Apr 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Accolade Inc

< Previous 1 2 3 4 5 6 Next >
ACCD Stock Earnings: Accolade Misses EPS, Beats Revenue for Q4 2024
ACCD stock results show that Accolade missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
Alphabet To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Accolade Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
Via Benzinga
Alabama’s Fertility Ruling Raises Challenges for Stocks of Fertility Benefits Providers
The recent Alabama State Supreme Court ruling on frozen embryos could have national repercussions. Here's what you need to know about it. 
Via InvestorPlace
A Glimpse Into The Expert Outlook On Accolade Through 7 Analysts
Via Benzinga
Nasdaq Edges Higher; Cutera Shares Jump
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Tuesday. The Dow traded down 0.53% to 37,484.13 while the NASDAQ rose 0.15% to 14,866.50. The S&P 500... 
Via Benzinga
Topics Stocks
Exposures US Equities
Accolade: Q3 Earnings Insights
Via Benzinga
A Preview Of Accolade's Earnings
Via Benzinga
Expert Ratings for Accolade
Via Benzinga
Crude Oil Gains Over 2%; TD SYNNEX Posts Downbeat Sales
U.S. stocks traded mostly lower midway through trading, with the Dow Jones falling around 180 points on Tuesday. The Dow traded down 0.49% to 37,499.41 while the NASDAQ rose 0.07% to 14,853.45. The S&P... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session. 
Via Benzinga
Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Shares of Accolade Fell This Week
The company's fiscal 2024 second-quarter numbers showed improvement, but analysts and investors were not impressed. 
Via The Motley Fool
Why Healthcare Technology Company Accolade Shares Are Surging Today
Accolade Inc (NASDAQ: ACCD) shares are trading higher after the company announced  
Via Benzinga
ACCD Stock Earnings: Accolade Beats EPS, Beats Revenue for Q3 2024
ACCD stock results show that Accolade beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024. 
Via InvestorPlace
Earnings Scheduled For January 8, 2024
Companies Reporting Before The Bell • Helen Of Troy (NASDAQ:HELE) is likely to report quarterly earnings at $2.75 per share on revenue of $544.39 million. 
Via Benzinga
Cathie Wood's Ark Invest Trims Bitcoin Exposure, Sells $2.9M Worth Of GBTC Shares Amid Crypto Market Volatility
On Thursday, Cathie Wood-led Ark Invest made a significant move by selling nearly $2.9 million worth of Grayscale Bitcoin Trust (OTC:GBTC) shares. This decision comes amidst a fluctuating crypto market... 
Via Benzinga
Azenta Reports Upbeat Earnings, Joins Talis Biomedical, Sally Beauty And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded higher, with the Dow Jones gaining around 500 points on Tuesday. Shares of Azenta, Inc. (NASDAQ: AZTA) rose on Tuesday after the company reported better-than-expected fourth-quarter... 
Via Benzinga
Topics Stocks
Exposures US Equities
1 Market-Beating Stock to Buy Near Its 52-Week High
This stock has been firing on all cylinders -- and it isn't about to stop. 
Via The Motley Fool
Alignment Healthcare's Valuation Shows Promise In A Competitive Market: Analyst
Alignment Healthcare Inc (NASDAQ: ALHC) announced that its California Medicare Advantage (MA) HMO – which represents roughly 89% of its MA membership – has maintained an overall 4 out of 5-star rating... 
Via Benzinga
Obesity Medication Insurance Coverage? Employers Embrace the Inclusion of Novo Nordisk's Wegovy in Health Coverage
Coverage for obesity medications, including Novo Nordisk A/S's (NYSE: NVO) Wegovy, is expected to expand among U.S. 
Via Benzinga
Why Eli Lilly Stock Crawled Higher Today
The pharmaceutical giant gets a lift from some good news on insurance coverage and a prognosticator's price-target lift. 
Via The Motley Fool
Raymond James Maintains Outperform Rating for Accolade: Here's What You Need To Know
Via Benzinga
Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Orchard Therapeutics plc (NASDAQ: ORTX) shares climbed 97.7% to $15.98 after the company agreed to be acquired by Japan's Kyowa Kirin for $16.00 per ADS in cash plus an additional contingent... 
Via Benzinga
Why Orchard Therapeutics Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
MaxCyte, Rivian Automotive And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures traded lower this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Conagra Brands, Constellation Brands And 3 Stocks To Watch Heading Into Thursday
With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Why Accolade Stock Is Falling After-Hours
Accolade, Inc. (NASDAQ: ACCD) shares are trading lower after-hours on Wednesday after the company announced results for the second-quarter 2024 
Via Benzinga
Accolade Gears Up For Q2 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Accolade, Inc. (NASDAQ: ACCD) is expected to release financial results for its fiscal second quarter 2024 after the closing bell on Oct. 4, 2023. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.